These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6893435)

  • 21. Treatment of asthma in children with triamcinolone acetonide aerosol.
    Sly RM; Imseis M; Frazer M; Joseph F
    J Allergy Clin Immunol; 1978 Aug; 62(2):76-82. PubMed ID: 670608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of different desoximetasone preparations compared to other topical corticosteroids in the vasoconstriction assay.
    Borelli C; Gassmueller J; Fluhr JW; Nietsch KH; Schinzel S; Korting HC
    Skin Pharmacol Physiol; 2008; 21(3):181-7. PubMed ID: 18523415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-response effect for adrenal suppression with repeated twice daily inhaled fluticasone propionate and triamcinolone acetonide in adult asthmatics.
    Wilson AM; McFarlane LC; Lipworth BJ
    Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1274-7. PubMed ID: 9351634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Desoximetasone: a new topical corticosteroid. Clinical evaluation.
    Mitra SC; Banerjee HP
    Indian J Dermatol; 1974 Oct; 20(1):7-15. PubMed ID: 4615062
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative study of desoximetasone ointment 0.25% versus fluocinonide ointment 0.05% in patients with psoriasis.
    Clin Ther; 1985; 8(1):118-25. PubMed ID: 3914368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, double-blind therapeutic trial of 0.25% desoxymethasone and 0.1% hydrocortisone 17-butyrate in the treatment of varicose eczema.
    Henry M; Hanks G; Whelan A
    Curr Med Res Opin; 1980; 6(7):502-6. PubMed ID: 6988176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Endogenous cortisol levels after intrathecal injection of triamicinolone acetonide in patients with neurological disease (author's transl)].
    Neu I; Reusche E; Rodiek S
    Dtsch Med Wochenschr; 1978 Sep; 103(35):1368-70. PubMed ID: 581070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of intranasal corticosteroids on adrenal, bone, and blood markers of systemic activity in allergic rhinitis.
    Wilson AM; Sims EJ; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):598-604. PubMed ID: 9802367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pituitary adrenal axis activity during topical treatment with 0,075 g% triamcinolone benetonide cream (author's transl)].
    Meynadier J; Guillot B
    Dermatologica; 1982 May; 164(5):327-30. PubMed ID: 6284561
    [No Abstract]   [Full Text] [Related]  

  • 30. Pituitary-adrenal function following topical triamcinolone acetonide and occlusion.
    Taylor KS; Malkinson FD; Gak C
    Arch Dermatol; 1965 Aug; 92(2):174-7. PubMed ID: 11850923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative distribution and metabolism of triamcinolone acetonide and cortisol in the rat embryomaternal unit.
    Rowland JM; Althaus ZR; Slikker W; Hendrickx AG
    Teratology; 1983 Jun; 27(3):333-41. PubMed ID: 6879456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the transplacental pharmacokinetics of cortisol and triamcinolone acetonide in the rhesus monkey.
    Slikker W; Althaus ZR; Rowland JM; Hill DE; Hendrickx AG
    J Pharmacol Exp Ther; 1982 Nov; 223(2):368-74. PubMed ID: 7131291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutaneous adverse reactions after intra-articular injection of triamcinolone acetonide.
    Ijsselmuiden OE; Knegt-Junk KJ; van Wijk RG; van Joost T
    Acta Derm Venereol; 1995 Jan; 75(1):57-8. PubMed ID: 7747537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the hypothalamic-pituitary-adrenal axis susceptibility upon single-dose i.m. depot versus long-acting i.v. triamcinolone acetonide therapy: a direct pharmacokinetic correlation.
    Abraham G; Demiraj F; Ungemach FR
    J Endocrinol; 2006 Nov; 191(2):491-6. PubMed ID: 17088419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The depot-form of glucocorticoid decreases cortisol but not ACTH and beta-endorphin levels in human plasma.
    Lypka A; Lazowski J; Szczudlik A; Wasek Z
    Horm Metab Res; 1983; 15(2):104-6. PubMed ID: 6298088
    [No Abstract]   [Full Text] [Related]  

  • 36. A comparison of treatment of oral lichen planus with topical tacrolimus and triamcinolone acetonide ointment.
    Laeijendecker R; Tank B; Dekker SK; Neumann HA
    Acta Derm Venereol; 2006; 86(3):227-9. PubMed ID: 16710580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma.
    Condemi JJ; Chervinsky P; Goldstein MF; Ford LB; Berger WE; Ayars GH; Rogenes PR; Edwards L; Pepsin PJ
    J Allergy Clin Immunol; 1997 Oct; 100(4):467-74. PubMed ID: 9338539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of urea on the penetration kinetics of topically applied corticosteroids.
    Wohlrab W
    Acta Derm Venereol; 1984; 64(3):233-8. PubMed ID: 6204485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The binding of topically applied glucocorticoids to rat skin.
    Baker JR; Christian RA; Simpson P; White AM
    Br J Dermatol; 1977 Feb; 96(2):171-8. PubMed ID: 843452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective observational study to compare efficacy of topical triamcinolone acetonide 0.1% oral paste, oral methotrexate, and a combination of topical triamcinolone acetonide 0.1% and oral methotrexate in moderate to severe oral lichen planus.
    Chauhan P; De D; Handa S; Narang T; Saikia UN
    Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29124831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.